|
1 |
Multiple Sclerosis Performance Test: Technical Development and Usability
Enthalten in Advances in therapy 3.5.2019: 1-15
|
|
|
|
2 |
APC mutations dysregulate alternative polyadenylation in cancer
Enthalten in Genome biology Bd. 25, 7.10.2024, Nr. 1, date:12.2024: 1-16
|
|
|
|
3 |
Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
Enthalten in Nature Communications Bd. 15, 21.2.2024, Nr. 1, date:12.2024: 1-29
|
|
|
|
4 |
Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo
Enthalten in Nature Communications Bd. 15, 1.2.2024, Nr. 1, date:12.2024: 1-14
|
|
|
|
5 |
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
Enthalten in Journal for ImmunoTherapy of Cancer Bd. 7, 22.5.2019, Nr. 1, date:12.2019: 1-9
|
|
|
|
6 |
Structural studies of the PARP-1 BRCT domain
Enthalten in BMC structural biology Bd. 11, 3.10.2011, Nr. 1, date:12.2011: 1-11
|
|
Administration
